RobbieMajznerMD

Pediatric Hematology & Oncology • Boston, MA

Physician

Join to view full profile

Dr. Majzner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Majzner's full profile

Already have an account?

Office
450 Brookline Ave
Boston, MA 02215
Phone+1 617-632-3270

Fax+1 617-632-4410

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2016
New York Presbyterian Hospital (Columbia Campus)Residency, Pediatrics, 2009 - 2012
Harvard Medical SchoolClass of 2009

Certifications & Licensure

MA State Medical License 2023 - 2026
CA State Medical License 2016 - 2024
MD State Medical License 2014 - 2017
NY State Medical License 2010 - 2014
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27Mdiffuse midline gliomas.
Michelle Monje, Jasia Mahdi, Robbie Majzner, Kristen W Yeom, Liora M Schultz
Nature. 2024-11-29
Intravenous and intracranial GD2-CAR T cells for H3K27Mdiffuse midline gliomas.
Michelle Monje, Jasia Mahdi, Robbie Majzner, Kristen W Yeom, Liora M Schultz
Nature. 2024-11-13
Orientation-dependent CD45 inhibition with viral and engineered ligands.
Marta T Borowska, Liu D Liu, Nathanael A Caveney, Kevin M Jude, Won-Ju Kim
Science Immunology. 2024-10-25

Journal Articles

Tumor Antigen Escape from CAR T-cell Therapy
Crystal L Mackall, Robbie G Majzner, Clinical Cancer Research

Abstracts/Posters

Identification of Dual Positive CD19+/CD3+ T Cells in an Apheresis Product Undergoing Chimeric Antigen Receptor (CAR) Transduction
Robbie G. Majzner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)
Robbie G. Majzner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
CAR T Cell Therapy for Neuroblastoma
Robbie Majzner, MD, Frontiers in Neurology, Orlando, FL, 12/9/2019

Press Mentions

Novel Treatment Shows Promise Against Rare Cancer in KidsApril 6th, 2023
Promising Treatment for Rare Cancer in Children Gives Hope to ExpertsApril 6th, 2023
Novel Treatment Shows Promise Against Rare Cancer in KidsApril 6th, 2023
Join now to see all